| [1] |
GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 2018, 392: 1015-1035.
|
| [2] |
Bjrkhaug ST, Aanes H, Neupane SP, et al. Characterization of gut microbiota composition and functions in patients with chronic alcohol overconsumption. Gut Microbes, 2019, 20: 1-13.
|
| [3] |
Mutlu EA, Gillevet PM, Rangwala H, et al. Colonic microbiome is altered in alcoholism. Am J Physiol Gastrointest Liver Physiol, 2012, 302: G966-978.
|
| [4] |
Shin NR, Whon TW, Bae JW. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol, 2015, 33: 496-503.
|
| [5] |
Hiippala K, Kainulainen V, Kalliomki M, et al. Mucosal prevalence and interactions with the epithelium indicate commensalism of Sutterella SPP. Front Microbiol, 2016, 7: 1706.
|
| [6] |
Yan AW, Fouts DE, Brandl J, et al. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology, 2011, 53: 96-105.
|
| [7] |
Llopis M, Cassard AM, Wrzosek L, et al. Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease. Gut, 2016, 65: 830-839.
|
| [8] |
Chen P, Miyamoto Y, Mazagova M, et al. Microbiota protects mice against acute alcohol-induced liver injury. Alcohol Clin Exp Res, 2015, 39: 2313-2323.
|
| [9] |
Keshavarzian A, Farhadi A, Forsyth CB, et al. Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. J Hepatol, 2009, 50: 538-547.
|
| [10] |
Meroni M, Longo M, Rametta R, et al. Genetic and epigenetic modifiers of alcoholic liver disease. Int J Mol Sci, 2018, 19:3857.
|
| [11] |
Cresci GA, Glueck B, McMullen MR, et al. Prophylactic tributyrin treatment mitigates chronic-binge ethanol-induced intestinal barrier and liver injury. J Gastroenterol Hepatol, 2017, 32: 1587-1597.
|
| [12] |
Rivière A, Selak M, Lantin D, et al. Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front Microbiol, 2016, 7: 979.
|
| [13] |
Grander C, Adolph TE, Wieser V, et al. Akkermansia muciniphila Recovery of ethanol-induced depletion ameliorates alcoholic liver disease. Gut, 2018, 67: 891-901.
|
| [14] |
Tremblay S, Romain G, Roux M, et al. Bile acid administration elicits an intestinal antimicrobial program and reduces the bacterial burden in two mouse models of enteric infection. Infect Immun, 2017, 85:e00942-16.
|
| [15] |
Alexander LM, Huang W, St?rkel P, et al. Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice. Gut, 2019, 68: 1504-1515.
|
| [16] |
Tuomisto S, Pessi T, Collin P, et al. Changes in gut bacterial populations and their translocation into liver and ascites in alcoholic liver cirrhotics. BMC Gastroenterol, 2014, 14: 40.
|
| [17] |
Llorente C, Jepsen P, Inamine T, et al. Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus. Nat Commun, 2017, 8: 1-15.
|
| [18] |
Leclercq S, De Saeger C, Delzenne N, et al. Role of inflammatory pathways, blood mononuclear cells, and gut-derived bacterial products in alcohol dependence. Biol Psychiatry, 2014, 76: 725-733.
|
| [19] |
Yang AM, Inamine T, Hochrath K, et al. Intestinal fungi contribute to development of alcoholic liver disease. J Clin Invest, 2017, 127: 2829-2841.
|
| [20] |
Chu H, Duan Y, Lang S, et al. The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease. J Hepatol, 2019. doi: 10.1016/j.jhep.2019.09.029.
|
| [21] |
Ponziani FR, Gerardi V, Pecere S, et al. Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications. World J Gastroenterol, 2015, 21: 12322-12333.
|
| [22] |
Kitagawa R, Kon K, Uchiyama A, et al. Rifaximin prevents ethanol-induced liver injury in obese KK-A mice through modulation of small intestinal microbiota signature. Am J Physiol Gastrointest Liver Physiol, 2019, 317:G707-G715.
|
| [23] |
Stadlbauer V, Mookerjee RP, Hodges S, et al. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. J Hepatol, 2008, 48: 945-951.
|
| [24] |
Han SH, Suk KT, Kim DJ, et al. Effects of probiotics (cultured Lactobacillus subtilis/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study. Eur J Gastroenterol Hepatol, 2015, 27:1300-1306.
|
| [25] |
Huang H, Lin Z, Zeng Y, et al. CProbiotic and glutamine treatments attenuate alcoholic liver disease in a rat model. Exp Ther Med, 2019, 18.
|
| [26] |
Roychowdhury S, Glueck B, Han Y, et al. A designer synbiotic attenuates chronic-binge ethanol-induced gut-liver injury in mice. Nutrients, 2019, 11:97.
|
| [27] |
Borody TJ, Campbell J. Fecal microbiota transplantation: techniques, applications, and issues. Gastroenterol Clin North Am, 2012, 41: 781-803.
|
| [28] |
Ferrere G, Wrzosek L, Cailleux F, et al. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice. J Hepatol, 2017, 66: 806-815.
|
| [29] |
Zhang X, Wang H, Yin P, et al. Flaxseed oil ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota in mice. Lipids Health Dis, 2017, 16: 44.
|
| [30] |
Yang X, He F, Zhang Y, et al. Inulin ameliorates alcoholic liver disease via suppressing LPS-TLR4-Mψ axis and modulating gut microbiota in mice. Alcohol Clin Exp Res, 2019, 43: 411-424.
|
| [31] |
Chen P, Torralba M, Tan J, et al. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. Gastroenterology, 2015, 148: 203-214.
|
| [32] |
Hartmann P, Hochrath K, Horvath A, et al. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice. Hepatology, 2018, 67: 2150-2166.
|
